Company intelligence / Profile preview

Zelta Clinical Trial Solutions

United States

Ownership: Private
Development stage: Other

Overview

Zelta by Merative is a cloud-based, unified clinical data management and acquisition platform designed to streamline and enhance clinical trial processes across all phases, therapeutic areas, and global regions. It provides customizable modules for electronic data capture (EDC), eConsent, eCOA/ePRO, RTSM, medical coding with AI, endpoint adjudication, and more, supporting both decentralized and traditional trials. Zelta is used by all top 20 pharmaceutical companies, has supported over 4,100 trials (including more than 500 phase III trials), and offers flexible, scalable solutions with global 24/7/365 support.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

BSI Life Sciences (CTMS, eTMF)Worldwide Clinical Trials (CRO partner)Alimentiv (study build automation)

Beyond the preview

Go deeper on Zelta Clinical Trial Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zelta Clinical Trial Solutions.

Explore the full profile